Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Bacterial Vaginosis Market Be Worth By 2029?

In recent times, the market size for bacterial vaginosis has witnessed substantial growth. The projections indicate an increase from $3.03 billion in 2024 to $3.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3%. The uptrend during the historic period is linked to the heightened use of point-of-care diagnostics, expansion of e-commerce, an upsurge in risky sexual activities, growth in STI vaccination, and broader access to healthcare.

In the upcoming years, the bacterial vaginosis market is projected to witness substantial expansion. It is predicted to reach $4.71 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. Factors contributing to the growth during this forecast period include the increasing prevalence of bacterial vaginosis, higher demand for functional foods, rising incidence of STIs, growing rate of women’s health issues, and increased awareness about menopause. The forecast period is also expected to see significant trends such as AI incorporation in diagnostics, usage of probiotics, advancements in STI testing at home, and the use of sustainable materials in women’s health devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

What External And Internal Drivers Are Influencing The Bacterial Vaginosis Market?

The bacterial vaginosis market is projected to grow due to a rise in cases of sexually transmitted infections (STIs). STIs, which often spread through sexual contact, can be because of bacteria, viruses, or parasites. The growth in STIs is attributed to factors such as unprotected sex, having multiple partners, a lack of knowledge, and antibiotic resistance. Bacterial vaginosis contributes to higher STI susceptibility as the vaginal bacterial equilibrium is disturbed, allowing infections like HIV and chlamydia to establish. For example, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based governmental agency, reported a notable surge in reported cases in 2022 compared to the preceding year in March 2024, noting an increase of 48% in gonorrhea, 34% in syphilis, and 16% in chlamydia. It is thus the escalating cases of STIs that are propelling the growth of the bacterial vaginosis market.

What Segmentation Insights Are Provided In The Bacterial Vaginosis Market Research?

The bacterial vaginosismarket covered in this report is segmented –

1) By Type: Point-Of-Care Testing; Laboratory Testing; Other Types

2) By Product: Below 15 Years; Between 15-45; Other Products

3) By Application: Antibiotics; Other Applications

4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests; Microscopy-based Tests; Immunoassays

2) By Laboratory Testing: Gram Staining; Polymerase Chain Reaction (PCR); DNA Probe Tests; Culture-based Testing

3) By Other Types: Home Testing Kits; Enzyme-linked Immunosorbent Assay (ELISA)

Which Market Trends Are Expected To Define The Future Of The Bacterial Vaginosis Market?

Key players in the bacterial vaginosis sector are concentrating their efforts on the creation of groundbreaking solutions such as multiplexed polymerase chain reaction (PCR) tests, aiming to improve the efficiency of diagnoses and treatments. Multiplexed PCR testing is a particular kind of polymerase chain reaction testing that enables multiple target DNA or RNA sequences to be amplified and detected in a single PCR experiment. To illustrate, in November 2022, the American biotech research firm, Cepheid, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), which delivers speedy results in less than an hour and identifies three vaginal infections – bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) using just one sample. The test can be conducted with either clinician-collected samples or self-collected swabs, using automated real-time PCR tech to boost diagnostic precision and enhance the effectiveness of treatments for women. The adaptability of the panel allows it to be utilized in a wide range of clinical environments, ensuring the accurate and efficient identification of vaginal infections.

Who Are The Leading Companies Driving The Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Bacterial Vaginosis Market?

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2025, By The Business Research Company

Vaginal Sling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

Vaginitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaginitis-therapeutics-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model